Holland Capital

Holland Capital, established in 1981, is a Dutch private equity firm headquartered in Amsterdam. It specializes in early-stage investments, primarily in the healthcare and technology sectors. The firm manages two active funds: one dedicated to supporting the growth of small and medium-sized enterprises (SMEs) in the Netherlands, and another focused on innovative healthcare businesses. Since its inception, Holland Capital has successfully realized over 115 investments.

Niels van Aalten

Partner

Willem Kingma

CFO

Dennis Mohnen

Investment Manager

Philip Wilms

Investment Manager

Sterre Witteveen

Investment Manager

Past deals in Private Equity Round

Ortius Pijnrevalidatie

Private Equity Round in 2018
Ortius Pijnrevalidatie is a rehabilitation clinic established in 2017, headquartered in Enschede, Netherlands, with additional locations in Heerenveen, Swalmen, Utrecht, and Voorburg. The company specializes in treating complex chronic pain conditions, including chronic low back pain and Ehlers-Danlos Syndrome, offering services tailored to these specific needs. Ortius collaborates with various partners to ensure accessible, affordable, and efficient care for its patients.

Telco accessories

Private Equity Round in 2017
Telco accessories play a significant role in today's mobile culture, offering users both freedom and a sense of identity. This business focuses on the manufacturing of a wide range of mobile accessories that cater to current consumer needs while also anticipating future trends. The brands within this sector are recognized as leaders, known for their commitment to innovation, design, and unique concepts that enhance the user experience. As mobile technology continues to evolve, the demand for high-quality accessories that complement devices remains strong, making this industry a vital component of the broader telecommunications landscape.

Prolira BV

Private Equity Round in 2016
Prolira BV is a medical technology company based in Utrecht, the Netherlands, founded in 2015. It specializes in developing DeltaScan, an innovative EEG-based medical device designed for the early detection of delirium, a form of acute brain failure. The DeltaScan system comprises a single-use electrode patch known as the DeltaScan Patch and a hardware/software module called the DeltaScan Monitor, which analyzes brain activity to support clinical decision-making. Prolira is dedicated to enabling timely and effective treatment for acute encephalopathy and delirium, conditions that affect approximately 20 million patients annually in hospitals across the European Union and the United States. By providing the first EEG bedside device with a validated proprietary algorithm, Prolira aims to help clinicians optimize patient recovery, ultimately reducing long-term cognitive impairment and hospital costs.

Sigmascreening

Private Equity Round in 2014
Sigmascreening B.V. is a medical device company based in Amsterdam, Netherlands, specializing in the development of innovative products for breast cancer screening. Established in 2010 as a spin-off from the Academic Medical Center Amsterdam, Sigmascreening focuses on enhancing digital mammography, the recognized standard for breast cancer detection. One of its notable products is the Sensitive Sigma Paddle, designed to measure the mechanical properties of breast tissue during compression, thereby improving the accuracy and effectiveness of screening processes. The company is committed to advancing technology in the field of breast cancer diagnostics through its ongoing product development efforts.

De Ridder b.v.

Private Equity Round in 2012
De Ridder b.v. is a supplier of products intended for use in the market of detainees. You can think of detainees, prisoners, asylum seekers and psychiatric patients staying in a detention environment.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.